Selective reporting of antibiotic susceptibility testing results: a promising antibiotic stewardship tool

Autor: Alain Lozniewski, Gianpiero Tebano, Alexandre Charmillon, Veronica Zanichelli, Nathalie Thilly, Sébastien Fougnot, Yosra Mouelhi, Céline Pulcini
Přispěvatelé: Service des maladies infectieuses et tropicales [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Maladies chroniques, santé perçue, et processus d'adaptation (APEMAC), Université de Lorraine (UL), Lady Davis Institute for Medical Research [Montréal], McGill University = Université McGill [Montréal, Canada]-Jewish General Hospital, Service des Maladies Infectieuses et Tropicales [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), ATOUTBIO, Service de microbiologie [CHU Nancy], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP], McGill University-Jewish General Hospital
Rok vydání: 2020
Předmět:
0301 basic medicine
Microbiology (medical)
medicine.medical_specialty
Susceptibility testing
medicine.drug_class
030106 microbiology
Antibiotics
Antibiotic susceptibility testing
Inappropriate Prescribing
Microbial Sensitivity Tests
Microbiology
03 medical and health sciences
Antimicrobial Stewardship
0302 clinical medicine
Antibiotic resistance
Selective reporting
Virology
Drug Resistance
Bacterial
medicine
Antimicrobial stewardship
Humans
030212 general & internal medicine
Cascade reporting
Antibiotic use
Medical prescription
Intensive care medicine
ComputingMilieux_MISCELLANEOUS
business.industry
Bacterial Infections
3. Good health
Anti-Bacterial Agents
Infectious Diseases
Practice Guidelines as Topic
Antibiotic Stewardship
Community setting
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Guideline Adherence
business
Zdroj: Expert Review of Anti-infective Therapy
Expert Review of Anti-infective Therapy, Expert Reviews, 2020, 18 (3), pp.251-262. ⟨10.1080/14787210.2020.1715795⟩
ISSN: 1744-8336
1478-7210
DOI: 10.1080/14787210.2020.1715795⟩
Popis: Introduction: Selective reporting of antibiotic susceptibility testing (AST) results is a potentially interesting tool for antibiotic stewardship. It consists of performing AST according to usual practices, but the results are reported to the prescriber only for a few antibiotics (i.e. first-line agents) or not reported at all when colonization is likely.Areas covered: We retrieved 20 studies exploring the impact of selective reporting. Overall, selective reporting is able to influence antibiotic use, both discouraging prescription in case of colonization, and promoting the selection of narrow-spectrum agents. Most studies concerned urine samples. Evidence on the impact on antibiotic resistance is insufficient. Unintended consequences were not observed, but evidence on this topic is scarce. Selective reporting is well implemented in a few countries, and a huge heterogeneity of practices exists.Expert opinion: Evidence shows that selective reporting can help reducing inappropriate and unnecessary antibiotic prescriptions. Uncomplicated urinary tract infections are probably the best initial target, both in hospital and community settings, but other non-severe infections can be a suitable option. The implementation of selective reporting should be promoted by the scientific community, with detailed practical guidelines, and its impact should be further assessed in large interventional studies.
Databáze: OpenAIRE
Externí odkaz: